Abeona Therapeutics (ABEO) Current Deferred Revenue (2010 - 2021)
Abeona Therapeutics (ABEO) posted quarterly Current Deferred Revenue of $296000.0 for Q4 2021, little changed year-over-year from $296000.0 in Q4 2020, and little changed quarter-over-quarter from $296000.0 in Q3 2021.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Current Deferred Revenue (2010 - 2021) Analysis & Trends
Abeona Therapeutics' Current Deferred Revenue history runs 12 years deep, the most recent figure standing at $296000.0 for Q4 2021.
- In Q4 2021, Current Deferred Revenue changed 0.0% year-over-year to $296000.0; the TTM figure through Dec 2021 stood at $296000.0 (changed 0.0% YoY), while the FY2021 annual figure was $296000.0, changed 0.0% from the prior year.
- Current Deferred Revenue for Q4 2021 stood at $296000.0, roughly flat from $296000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $2.6 million in Q4 2017, with the low at $296000.0 in Q4 2018.
- The 5-year median for Current Deferred Revenue is $296000.0 (2018), against an average of $560736.8.
- The sharpest annual moves came in 2017 and 2018: Current Deferred Revenue jumped 331.89% in 2017, then plunged 88.62% in 2018.
- Abeona Therapeutics' Current Deferred Revenue stood at $2.6 million in 2017, then slumped by 88.62% to $296000.0 in 2018, then changed by 0.0% to $296000.0 in 2019, then changed by 0.0% to $296000.0 in 2020, then changed by 0.0% to $296000.0 in 2021.
- Business Quant data shows ABEO's Current Deferred Revenue at $296000.0 in Q4 2021, $296000.0 in Q3 2021, and $296000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 296,000.00 |
| Sep 30, 2021 | 296,000.00 |
| Jun 30, 2021 | 296,000.00 |
| Mar 31, 2021 | 296,000.00 |
| Dec 31, 2020 | 296,000.00 |
| Sep 30, 2020 | 296,000.00 |
| Jun 30, 2020 | 296,000.00 |
| Mar 31, 2020 | 296,000.00 |
| Dec 31, 2019 | 296,000.00 |
| Sep 30, 2019 | 296,000.00 |
| Jun 30, 2019 | 296,000.00 |
| Mar 31, 2019 | 296,000.00 |
| Dec 31, 2018 | 296,000.00 |
| Jun 30, 2018 | 800,000.00 |
| Mar 31, 2018 | 1.60 Mn |
| Dec 31, 2017 | 2.60 Mn |
| Sep 30, 2017 | 602,000.00 |
| Jun 30, 2017 | 602,000.00 |
| Mar 31, 2017 | 602,000.00 |
| Dec 31, 2016 | 602,000.00 |